From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforce
Cardiovasc Diabetol. 2026 Feb 23;25(1):66. doi: 10.1186/s12933-026-03098-z.ABSTRACTInternational guidelines define standards of care for type 2 diabetes (T2D), obesity, cardiovascular disease (CVD), metabolic dysfunction-associated steatotic liver disease (MASLD) and chronic kidney disease (CKD). Ye

